Trial intelligence / Profile preview

Low Dose GnRHa vs Ultra-short Protocol for Poor Ovarian Response

NCT02940535Unknown

Start
Dec 2016
Primary completion
Dec 2019
Modality
Peptides, Small Molecules
Countries
1
01

Overview

Randomised, open-label trial of triptorelin in poor ovarian response (POR) (2 arms). Primary endpoint: live birth at 3 years. Status: unknown.

02

Drugs

triptorelin
03

Conditions

poor ovarian response (POR)

Beyond the preview

Go deeper on NCT02940535.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02940535.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call